当前位置：
X-MOL 学术
›
Cancer Gene Ther.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Correction: miR-200c inhibits TGF-β-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer
Cancer Gene Therapy ( IF 6.4 ) Pub Date : 2020-11-05 , DOI: 10.1038/s41417-020-00241-0 Xinliang Zhou , Xinyi Men , Riyang Zhao , Jing Han , Zhisong Fan , Yudong Wang , Yalei Lv , Jing Zuo , Lianmei Zhao , Meixiang Sang , Xian-De Liu , Baoen Shan
Cancer Gene Therapy ( IF 6.4 ) Pub Date : 2020-11-05 , DOI: 10.1038/s41417-020-00241-0 Xinliang Zhou , Xinyi Men , Riyang Zhao , Jing Han , Zhisong Fan , Yudong Wang , Yalei Lv , Jing Zuo , Lianmei Zhao , Meixiang Sang , Xian-De Liu , Baoen Shan
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
中文翻译：
纠正：miR-200c通过靶向ZEB1和ZEB2抑制胃癌中TGF-β诱导的EMT恢复曲妥珠单抗敏感性
该文件的修订版已经发布，可以通过文件顶部的链接进行访问。
更新日期：2020-11-05
中文翻译：
纠正：miR-200c通过靶向ZEB1和ZEB2抑制胃癌中TGF-β诱导的EMT恢复曲妥珠单抗敏感性
该文件的修订版已经发布，可以通过文件顶部的链接进行访问。
京公网安备 11010802027423号